A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.

Citation

• Barbour, A., O'Rourke, N., Samra, J. S., Haghighi, K. S., Kench, J., Mitchell, J., . . . Goldstein, D. (2015). A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.. Journal of Clinical Oncology, 33(3_suppl), 387. doi:10.1200/jco.2015.33.3_suppl.387

Digital Object Identifier (doi)

• 10.1200/jco.2015.33.3_suppl.387

Web Of Science Accession Number

Start Page

• 387

End Page

• 387

Volume

• 33

Issue

• 3_suppl

Place Of Publication

Abstract

UOW Authors

•   Aghmesheh, Morteza (external author)

Publication Date

• 2015

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Barbour, A., O'Rourke, N., Samra, J. S., Haghighi, K. S., Kench, J., Mitchell, J., . . . Goldstein, D. (2015). A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.. Journal of Clinical Oncology, 33(3_suppl), 387. doi:10.1200/jco.2015.33.3_suppl.387

Digital Object Identifier (doi)

• 10.1200/jco.2015.33.3_suppl.387

Web Of Science Accession Number

Start Page

• 387

End Page

• 387

Volume

• 33

Issue

• 3_suppl

Place Of Publication